FK866, is the earliest discovered NAMPT inhibitor, which selectively inhibits NAMPT, resulting in a decrease in NAD+ levels, and then inhibiting the growth of tumor cells (Hasmann and Schemainda, 2003). This evidence concerns the gene NAMPT and neoplasm.